SMITH, ANDREW
 Distribuzione geografica
Continente #
NA - Nord America 12.115
AS - Asia 10.585
EU - Europa 7.233
SA - Sud America 1.312
AF - Africa 198
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 4
Totale 31.478
Nazione #
US - Stati Uniti d'America 11.795
VN - Vietnam 3.080
SG - Singapore 3.056
IT - Italia 2.214
CN - Cina 1.976
HK - Hong Kong 1.085
BR - Brasile 974
DE - Germania 921
RU - Federazione Russa 864
SE - Svezia 655
IE - Irlanda 645
GB - Regno Unito 427
FR - Francia 326
IN - India 307
AT - Austria 250
CA - Canada 202
UA - Ucraina 192
KR - Corea 166
BD - Bangladesh 133
FI - Finlandia 127
NL - Olanda 120
AR - Argentina 119
ID - Indonesia 113
TR - Turchia 112
ES - Italia 99
IQ - Iraq 98
DK - Danimarca 95
JP - Giappone 79
ZA - Sudafrica 74
MX - Messico 72
PL - Polonia 64
EC - Ecuador 55
CH - Svizzera 54
PK - Pakistan 48
SA - Arabia Saudita 46
PH - Filippine 45
VE - Venezuela 43
CO - Colombia 34
BE - Belgio 32
AU - Australia 30
PY - Paraguay 29
UZ - Uzbekistan 29
MA - Marocco 26
LT - Lituania 25
MY - Malesia 25
TN - Tunisia 19
TW - Taiwan 19
CL - Cile 18
PE - Perù 17
AE - Emirati Arabi Uniti 16
IR - Iran 16
JO - Giordania 16
CZ - Repubblica Ceca 15
GR - Grecia 15
TH - Thailandia 15
EG - Egitto 14
UY - Uruguay 14
KZ - Kazakistan 13
NP - Nepal 13
RO - Romania 13
DZ - Algeria 12
KE - Kenya 12
IL - Israele 11
OM - Oman 11
CR - Costa Rica 10
ET - Etiopia 10
AZ - Azerbaigian 9
HR - Croazia 9
NO - Norvegia 9
PT - Portogallo 9
BG - Bulgaria 8
LB - Libano 8
AL - Albania 7
BO - Bolivia 7
JM - Giamaica 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
PA - Panama 6
RS - Serbia 6
BY - Bielorussia 5
MN - Mongolia 5
SY - Repubblica araba siriana 5
HN - Honduras 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GA - Gabon 3
KW - Kuwait 3
LY - Libia 3
MU - Mauritius 3
NG - Nigeria 3
NI - Nicaragua 3
SN - Senegal 3
BH - Bahrain 2
BN - Brunei Darussalam 2
GE - Georgia 2
Totale 31.437
Città #
Singapore 1.737
Ann Arbor 1.699
Ashburn 1.158
Hong Kong 1.046
San Jose 955
Ho Chi Minh City 934
Milan 807
Hanoi 721
Dublin 630
Frankfurt am Main 593
Fairfield 585
Chandler 581
Wilmington 460
New York 380
Woodbridge 365
Houston 343
Santa Clara 309
Dearborn 306
Los Angeles 285
Dallas 267
Seattle 260
Beijing 256
Chicago 211
Vienna 210
Hefei 201
Princeton 191
Cambridge 184
Shanghai 161
The Dalles 160
Jacksonville 150
Seoul 145
Nanjing 135
São Paulo 122
Lauterbourg 115
Dong Ket 111
Buffalo 104
Da Nang 101
Council Bluffs 100
Moscow 93
Helsinki 78
Rome 74
Ha Long 73
Haiphong 72
Orem 67
Hải Dương 65
Quận Bình Thạnh 63
Jakarta 62
Kent 59
London 58
Biên Hòa 57
Guangzhou 54
Chennai 53
Toronto 50
Lawrence 49
Thái Nguyên 48
Tokyo 48
Nanchang 46
Nuremberg 46
Warsaw 45
Baghdad 43
Munich 43
Vũng Tàu 43
Denver 42
Montreal 42
Altamura 41
Brooklyn 41
Can Tho 41
Ninh Bình 40
Shenyang 40
Atlanta 38
Bắc Ninh 38
Falls Church 37
Lissone 37
Johannesburg 36
Manchester 36
San Diego 36
Poplar 34
Bắc Giang 32
Fremont 32
Stockholm 32
Zurich 32
Basingstoke 31
Phoenix 31
Changsha 30
Salt Lake City 30
Amsterdam 29
Boardman 29
Hebei 29
Ottawa 29
Pune 29
Zhengzhou 29
Andover 28
Sesto San Giovanni 28
Tashkent 28
Brussels 27
Florence 27
Quận Một 27
Quận Phú Nhuận 27
Mumbai 26
Rio de Janeiro 25
Totale 19.713
Nome #
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 590
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 580
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 541
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 532
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 470
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 460
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 453
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 448
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 439
The putative role of MALDI-MSI in the study of Membranous Nephropathy 417
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 416
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 400
The proteomic landscape of renal tumors 389
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 387
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 386
MALDI imaging in Fabry nephropathy: a multicenter study 384
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 373
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 370
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 369
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 363
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 363
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 362
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 359
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
Proteomics for the diagnosis of thyroid lesions: Preliminary report 354
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 351
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 347
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 345
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 342
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 342
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 337
Proteomics for the study of new biomarkers in Fabry disease: State of the art 337
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 330
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 326
Tumor size, stage and grade alterations of urinary peptidome in RCC 312
Proteome analysis in thyroid pathology 305
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 305
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 304
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 302
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 300
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 299
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 285
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 280
A molecular imaging approach to individuate tumour infiltrating lymphocytes 279
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 278
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 269
Intraluminal proteome and peptidome of human urinary extracellular vesicles 269
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 262
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 262
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 260
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 252
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 248
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 247
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 238
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 238
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 237
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 237
The role of fine needle aspiration of orbital lesions: A case series 236
MALDI-MS imaging in the study of glomerulonephritis 233
Single-follicle spatial proteomics of the whole ovary by MALDI mass spectrometry imaging: towards the identification of protein-markers of the follicle's quality 232
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 231
Machine learning approaches in MALDI-MSI: clinical applications 227
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 225
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 223
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 223
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 216
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 215
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 212
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 208
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 203
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 201
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 201
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 199
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 199
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 198
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 192
The putative role of MALDI-MSI in the study of Membranous Nephropathy 191
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 189
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 189
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 189
The putative role of MALDI-MSI in the study of Membranous Nephropathy 184
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 181
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 180
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 178
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 177
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 176
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 176
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 175
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 170
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 168
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 168
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 168
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 166
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 165
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 165
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 157
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 157
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 157
Does the urinary proteome reflect ccrcc stage and grade progression? 154
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 153
Totale 28.092
Categoria #
all - tutte 93.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 0 124 243
2021/20221.493 119 144 91 162 114 145 39 83 61 113 149 273
2022/20232.579 300 692 242 199 101 394 47 200 172 37 113 82
2023/20242.140 75 85 82 145 198 585 438 52 132 36 82 230
2024/20255.111 226 452 344 214 439 183 310 196 600 785 567 795
2025/202614.213 2.847 1.521 1.056 1.547 1.540 639 1.987 650 1.050 1.246 130 0
Totale 32.428